Guide

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…

Certara2025 年 11 月 7 日

On-Demand Webinar

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Watch the on-demand webinar on avoiding drug launch failure. Learn how smarter development, evidence, and…

Certara2025 年 11 月 6 日

On-Demand Webinar

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…

Certara2025 年 11 月 3 日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025 年 10 月 31 日

Blog

Key lessons & opportunities in applying NCA and PopPK to ADCs

Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…

Certara2025 年 10 月 24 日

Blog

Bottlenecks to breakthroughs: Tackling challenges in QSP modeling

QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…

Certara2025 年 10 月 22 日

On-Demand Webinar

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…

Certara2025 年 10 月 21 日

Video

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…

Certara2025 年 10 月 16 日

Video

Immuno-oncology (IO) Simulator in Certara IQ™

Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…

Certara2025 年 10 月 16 日

Video

ADC Modeling and Design with Certara IQ™

Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…

Certara2025 年 10 月 16 日

建模与模拟

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

按时交付：借助定量药理学分析洞见，顺利推进监管申报

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Key lessons & opportunities in applying NCA and PopPK to ADCs

Bottlenecks to breakthroughs: Tackling challenges in QSP modeling

AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Immuno-oncology (IO) Simulator in Certara IQ™

ADC Modeling and Design with Certara IQ™

订阅时事通讯

快捷链接

解决方案

联系我们